Stefanie Pantenburg scite author profile

CHD, time from occlusion to treatment and smoking influence BCVA at baseline and at month 1 (prognostic effect). Patients treated within 12 h are more likely to profit from treatment. In multivariate analysis, there is no clear trend to benefit from LIF even in patients with young age, no CHD and early treatment. Based on this preliminary report on a rather small sample size, we do not recommend LIF in CRAO patients.

show abstract

Kardiovaskuläre Risikofaktoren bei Patienten mit frischem, nicht-arteriitischem Zentralarterienverschluss - Bedeutung der systematischen Abklärung und Einfluss auf die Therapie

Pantenburg¹

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Stefanie Pantenburg

Cardiovascular Risk Factors in Central Retinal Artery Occlusion

Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment

Kardiovaskuläre Risikofaktoren bei Patienten mit frischem, nicht-arteriitischem Zentralarterienverschluss - Bedeutung der systematischen Abklärung und Einfluss auf die Therapie

Contact Info

Product

Resources

About